Juvederm Voluma is the newest HA (hyaluronic acid) soft tissue filler to gain FDA approval. It has been available in Europe since 2005 and is used in 72 countries worldwide. Juvederm Voluma is the newest filler in the family of Juvederm products, and is formulated with lidocaine for added comfort during treatment. This current form, with the added local anesthetic, is known as Juvederm Voluma XC.
Dr. Greene serves as a key opinion leader and national trainer for Allergan, and trains other physicians on proper injection techniques using Botox, Juvederm Ultra, Juvederm Ultra Plus, and Juvederm Voluma. He was selected as one of the first physicians in South Florida to offer Juvederm Voluma XC.
What makes JUVEDERM VOLUMA different
The loss of midface volume is one of the hallmarks of facial aging. This occurs in varying degrees of severity, and can lead to significant changes in the facial appearance. One of the most noticeable changes is the loss of cheekbone definition. Historically, this was addressed with surgery to tighten the overlying skin and lift the deeper soft tissues. More recently, volumizing fillers have been used to provide a similar ‘lift’ without surgery. The goal is to restore volume in the midface to create a natural, youthful face.
Juvederm Voluma is the first filler formulated with lidocaine that is FDA approved to restore age-related volume changes in the cheeks. Unlike other fillers commonly used to treat the midface, Voluma is a hyaluronic acid (HA) filler. HA fillers are made from long chains of sugars that occur naturally in the skin. Juvederm Voluma is unique in that the HA is cross-linked through a process called Vycross that helps provide an excellent lifting capacity. This special cross-linking also helps to avoid degradation, making Voluma last almost twice as long as other fillers. Studies have shown that it can last up to 2 years. And since it is an HA filler, it can be molded and shaped into the desired contour after injection.